U.S. advisers say keep Glaxo's Avandia on the market (Reuters)

[Mgtrben news]

Reuters - GlaxoSmithKline Plc's diabetes drug Avandia should be allowed to stay on the market but with additional warnings, U.S. health advisers recommended on Wednesday, easing a threat of further costly litigation that could have followed a ban.

Source (http://us.rd.*****.com/dailynews/rss/topstories/*http://news.*****.com/s/nm/20100715/bs_nm/us_glaxo_avandia)